Some reports suggest that the overexpression of kallistatin improves myocardial ischemia-reperfusion damage, inhibits heart remodeling after a myocardial infarction (MI), and alleviates hypertension in animal models, suggesting a close relationship between kallistatin and CVD [8]. The gene discussed is SERPINA4; the disease is hypertensive disorder.